Cardiac Markers is an innovative heart health technology that transforms consumer smartwatches into advanced cardiac warning monitors. With the aim of assisting the growing telehealth market, this software has the potential to eliminate the need for in-person doctor’s visits or hospital trips, presenting a significant opportunity for growth and profitability.
One notable aspect of Cardiac Markers is its ability to address the need for widespread QT self-monitoring for drug toxicity. With over 260 drugs known to cause QT lengthening, which can lead to serious heart problems, there is an immediate need for reliable monitoring. By integrating a consumer’s compatible fitness or smartwatch device with Cardiac Markers’ service, managing measurements to prevent potential fatalities due to prolonged QT becomes easier.
Currently in phase II testing, Cardiac Markers’ software has shown promising results, offering the opportunity to make a life-saving difference for millions of patients. This product has potential applications in multiple health technology markets, including the smartwatch, fitness device, and home health sectors. Manufacturers of wearable devices and clinicians with a focus on heart health are likely to consider adding Cardiac Markers’ ECG screening service as an emerging and breakthrough benefit to their existing offerings.